Anne Drewry1, Nicholas M Mohr2. 1. Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO. 2. Departments of Emergency Medicine, Anesthesia, and Epidemiology, University of Iowa Carver College of Medicine, Iowa City, IA.
Abstract
OBJECTIVE: Temperature abnormalities are recognized as a marker of human disease, and the therapeutic value of temperature is an attractive treatment target. The objective of this synthetic review is to summarize and critically appraise evidence for active temperature management in critically ill patients. DATA SOURCES: We searched MEDLINE for publications relevant to body temperature management (including targeted temperature management and antipyretic therapy) in cardiac arrest, acute ischemic and hemorrhagic stroke, traumatic brain injury, and sepsis. Bibliographies of included articles were also searched to identify additional relevant studies. STUDY SELECTION: English-language systematic reviews, meta-analyses, randomized trials, observational studies, and nonhuman data were reviewed, with a focus on the most recent randomized control trial evidence. DATA EXTRACTION: Data regarding study methodology, patient population, temperature management strategy, and clinical outcomes were qualitatively assessed. DATA SYNTHESIS: Temperature management is common in critically ill patients, and multiple large trials have been conducted to elucidate temperature targets, management strategies, and timing. The strongest data concerning the use of therapeutic hypothermia exist in comatose survivors of cardiac arrest, and recent trials suggest that appropriate postarrest temperature targets between 33°C and 37.5°C are reasonable. Targeted temperature management in other critical illnesses, including acute stroke, traumatic brain injury, and sepsis, has not shown benefit in large clinical trials. Likewise, trials of pharmacologic antipyretic therapy have not demonstrated improved outcomes, although national guidelines do recommend treatment of fever in patients with stroke and traumatic brain injury based on observational evidence associating fever with worse outcomes. CONCLUSIONS: Body temperature management in critically ill patients remains an appealing therapy for several illnesses, and additional studies are needed to clarify management strategies and therapeutic pathways.
OBJECTIVE: Temperature abnormalities are recognized as a marker of human disease, and the therapeutic value of temperature is an attractive treatment target. The objective of this synthetic review is to summarize and critically appraise evidence for active temperature management in critically ill patients. DATA SOURCES: We searched MEDLINE for publications relevant to body temperature management (including targeted temperature management and antipyretic therapy) in cardiac arrest, acute ischemic and hemorrhagic stroke, traumatic brain injury, and sepsis. Bibliographies of included articles were also searched to identify additional relevant studies. STUDY SELECTION: English-language systematic reviews, meta-analyses, randomized trials, observational studies, and nonhuman data were reviewed, with a focus on the most recent randomized control trial evidence. DATA EXTRACTION: Data regarding study methodology, patient population, temperature management strategy, and clinical outcomes were qualitatively assessed. DATA SYNTHESIS: Temperature management is common in critically ill patients, and multiple large trials have been conducted to elucidate temperature targets, management strategies, and timing. The strongest data concerning the use of therapeutic hypothermia exist in comatose survivors of cardiac arrest, and recent trials suggest that appropriate postarrest temperature targets between 33°C and 37.5°C are reasonable. Targeted temperature management in other critical illnesses, including acute stroke, traumatic brain injury, and sepsis, has not shown benefit in large clinical trials. Likewise, trials of pharmacologic antipyretic therapy have not demonstrated improved outcomes, although national guidelines do recommend treatment of fever in patients with stroke and traumatic brain injury based on observational evidence associating fever with worse outcomes. CONCLUSIONS: Body temperature management in critically ill patients remains an appealing therapy for several illnesses, and additional studies are needed to clarify management strategies and therapeutic pathways.
Authors: Scott E Kasner; Theodore Wein; Paisith Piriyawat; Carlos E Villar-Cordova; Julio A Chalela; Derk W Krieger; Lewis B Morgenstern; Stephen E Kimmel; James C Grotta Journal: Stroke Date: 2002-01 Impact factor: 7.914
Authors: Heleen M den Hertog; H Bart van der Worp; H Maarten A van Gemert; Ale Algra; L Jaap Kappelle; Jan van Gijn; Peter J Koudstaal; Diederik W J Dippel Journal: Lancet Neurol Date: 2009-03-16 Impact factor: 44.182
Authors: Josef Dankiewicz; Tobias Cronberg; Gisela Lilja; Janus C Jakobsen; Helena Levin; Susann Ullén; Christian Rylander; Matt P Wise; Mauro Oddo; Alain Cariou; Jan Bělohlávek; Jan Hovdenes; Manoj Saxena; Hans Kirkegaard; Paul J Young; Paolo Pelosi; Christian Storm; Fabio S Taccone; Michael Joannidis; Clifton Callaway; Glenn M Eastwood; Matt P G Morgan; Per Nordberg; David Erlinge; Alistair D Nichol; Michelle S Chew; Jacob Hollenberg; Matthew Thomas; Jeremy Bewley; Katie Sweet; Anders M Grejs; Steffen Christensen; Matthias Haenggi; Anja Levis; Andreas Lundin; Joachim Düring; Simon Schmidbauer; Thomas R Keeble; Grigoris V Karamasis; Claudia Schrag; Edith Faessler; Ondrej Smid; Michal Otáhal; Marco Maggiorini; Pedro D Wendel Garcia; Paul Jaubert; Jade M Cole; Miroslav Solar; Ola Borgquist; Christoph Leithner; Samia Abed-Maillard; Leanlove Navarra; Martin Annborn; Johan Undén; Iole Brunetti; Akil Awad; Peter McGuigan; Roy Bjørkholt Olsen; Tiziano Cassina; Philippe Vignon; Halvor Langeland; Theis Lange; Hans Friberg; Niklas Nielsen Journal: N Engl J Med Date: 2021-06-17 Impact factor: 91.245
Authors: Francis Kim; Graham Nichol; Charles Maynard; Al Hallstrom; Peter J Kudenchuk; Thomas Rea; Michael K Copass; David Carlbom; Steven Deem; W T Longstreth; Michele Olsufka; Leonard A Cobb Journal: JAMA Date: 2014-01-01 Impact factor: 56.272